Latham & Watkins advised Neumora, and Cooley advised the underwriters. Neumora Therapeutics, Inc. announced the pricing of its initial public offering of 14,710,000 shares of its common...
Neumora Therapeutics’ $250.1 Million Initial Public Offering
Definitive Healthcare’s $52 Million Acquisition of Populi
Cooley advised Definitive Healthcare on the deal. Definitive Healthcare (Nasdaq: DH) announced its acquisition of Populi for $52 million in an all-cash transaction. This acquisition furthers Definitive...
Monolith Materials’ $300 Million Funding Round
Kirkland & Ellis advised TPG Rise Climate and The Rise Fund on the deal while Cooley represented Monolith. Monolith closed its latest investment round of more than...
Alpargatas’ $475 Million Series B Investment in Rothy’s
Mayer Brown represented Alpargatas S.A. in the transaction while Cooley advised Rothy. Alpargatas S.A., a Brazil-based, global footwear company creator of the famous flip flop “Havaianas,”...
Groww’s $251 Million Series E Round
Cooley LLP advised Groww on the deal, AZB & Partners advised Tiger Global, while Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Sequoia Capital and Tiger...